PO23-755 EZETIMIBE/SIMVASTATIN MORE FAVORABLY INFLUENCES LIPOPROTEIN/APOLIPOPROTEIN RATIOS THAN ATORVASTATIN MONOTHERAPY IN PATIENTS WITH TYPE 2 DIABETES

✍ Scribed by Guyton, J.R.; Goldberg, R.B.; Mazzone, T.; Weinstock, R.S.; Polis, A.; Rosenberg, E.; Edwards, P.; Tershakovec, A.M.

• Book ID: 118635595
• Publisher: Elsevier Science
• Year: 2007
• Tongue: English
• Weight: 112 KB
• Volume: 8
• Category: Article
• ISSN: 1567-5688
• DOI: 10.1016/s1567-5688(07)71765-8